Bode John B

Director John B Bode purchased 5,000 shares of ZVRA at $9.16 on 2025-08-19, adding to 40,000 prior holdings; stock down 20.9% in 30 days.

Director John B Bode purchased 5,000 shares at $9.16, increasing holdings to 45,000 shares (+12.5% vs. pre-transaction holdings) at a price -27.4% from the 52-week high and -20.9% over the past 30 days. His prior 5 trades at ZVRA show a 4 of 5 well-timed pattern at the 90-day mark, suggesting he historically purchases near local lows at this ticker. However, the company's recent fundamentals are challenged: annual revenue declined 14.0%, the stock trades at a P/E of 185.60, and despite a recent quarterly net income of $74.7M, the company was unprofitable on a full-year basis. The purchase arrives after sharp recent price weakness, which aligns with his historical buying pattern at ZVRA, but elevated valuation metrics and deteriorating annual profitability warrant scrutiny of whether this represents the beginning of recovery or a continuation of structural decline.

Director Bode John B purchased 10,000 shares of ZVRA at $7.96 on 2025-03-19, expanding holdings 33.3% to 40,000 shares.

Bode John B purchased 10,000 shares at $7.96, a price 0.62% below the current $8.01 level and within the 52-week range of $4.26–$9.68. The transaction represents a 33.3% increase in his personal shareholdings from 30,000 to 40,000 shares. His prior trading history at ZVRA shows strong timing: 4 of 5 prior buys were well-timed at the 90-day mark, with a 2024-07-12 purchase returning +12.7% in 30 days and +35.0% in 90 days. However, fundamentals present a significant headwind—the company reported net income of $-33,225,000.00 for its most recent full fiscal year and is currently unprofitable, with annual revenue declining 14.0% year-over-year. The purchase occurs against a backdrop of operational challenges rather than a recovery signal, warranting attention to whether this reflects conviction in a turnaround strategy or routine portfolio activity.

ZVRA Director Bode buys 10,000 shares at $5.87; 50% increase in holdings, stock +34.0% in 30 days

Director John B Bode purchased 10,000 shares at $5.87 on 2024-07-12, increasing his holdings by 50.0% from 20,000 to 30,000 shares, for a total value of $58,661.00. The purchase occurred as the stock rebounded strongly—up +34.0% over the prior 30 days and +30.6% over 90 days from the transaction date. At the same ticker, Bode's prior trading record shows 4 of 5 earlier buys were well-timed at the 90-day mark, suggesting consistent execution discipline, though his ZVRA-specific purchases have produced mixed results (ranging from -10.6% to +15.4% over 30 days). The company remains unprofitable with net income of $-16.6M in the latest full year, though it posted strong annual revenue growth of +162.6%, adding fundamental context to the valuation environment in which this buy occurred.